Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

12

Number of overlapping holdings

25.0%

% of CANC's 48 holdings also in BBP

19.7%

% of BBP's 65 holdings also in CANC

Overlap by Weight
Sector Drift (CANC minus BBP)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in BBP
Overlap
BEIGENE LTD. SPONSORED ADR 2.7% 2.3% 2.3%
ZAI LAB LTD. UNSPONSORED ADR 3.0% 2.2% 2.2%
AMGEN INC 2.8% 2.0% 2.0%
BRIDGEBIO PHARMA, INC. 4.5% 1.9% 1.9%
EXELIXIS INC 3.8% 1.8% 1.8%

Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to BBP
REVOLUTION MEDICINES, INC. 5.7%
ELI LILLY & CO 5.4%
ROCHE HOLDINGS LTD-SPONS ADR 5.1%
NOVARTIS AG 4.3%
ASTRAZENECA PLC 4.2%
BRISTOL-MYERS SQUIBB CO 4.0%
NUVALENT, INC. CLASS A 3.9%
SUMMIT THERAPEUTICS INC 3.9%
GENMAB A/S SPONSORED ADR 3.4%
MERUS N.V. 3.2%
CANC Underweight Relative to BBP
INTRA-CELLULAR THERAPIES INC -2.6%
SAGE THERAPEUTICS INC -2.2%
AXSOME THERAPEUTICS, INC. -2.1%
SPRINGWORKS THERAPEUTICS, INC. -2.1%
HALOZYME THERAPEUTICS INC -2.1%
TG THERAPEUTICS INC -2.1%
ASCENDIS PHARMA A/S -1.8%
PTC THERAPEUTICS INC -1.8%
DYNAVAX TECHNOLOGIES CORP -1.8%
MADRIGAL PHARMACEUTICALS, INC. -1.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY